Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuralgia × Electroacupuncture × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Neoplasms 5 Pain 4 Sleep Initiation and Maintenance Disorders 3 Prostatic Neoplasms 3 Vomiting 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Nausea 2 Depression 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Anxiety Disorders 2 Acupuncture 2 Xerostomia 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Sarcoma, Ewing 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Prostatic Hyperplasia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Ileus 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Opioid-Induced Constipation 1 Obesity, Abdominal 1 Obesity 1 Neuropathy, Painful 1 Neuralgia 1

Interventions

Pregabalin 4 Lidocaine 4 Surveys and Questionnaires 3 Bupivacaine 3 ziconotide 2 Transcranial Magnetic Stimulation 2 Oxycodone 2 Gabapentin 2 onabotulinum toxin A 1 Yoga 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Transcutaneous Electric Nerve Stimulation 1 Thalidomide 1 Telmisartan 1 Tapentadol 1 Sodium Chloride 1 Saline Solution 1 Radiofrequency Ablation 1 Plastic Surgery Procedures 1 Paclitaxel 1 Oxaliplatin 1 Morphine 1 Methadone 1 Manipulation, Osteopathic 1 Low-Level Light Therapy 1 Lidoderm 1 Hypnosis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04917796 2026-01-30

ACT

Dana-Farber Cancer Institute

Phase NA Active not recruiting

Neuropathy, Painful, Agnosia, Neuralgia, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡